The European Pharmacopoeia (Ph. Eur.) Commission granted observer status to the Ethiopian Food and Drug Administration (EFDA) during its 174th session (November 2022). This decision demonstrates the dynamism of the European Pharmacopoeia, which now has 31 observers from around the world, in addition to its 40 members (39 European states and the European Union).
This status allows EFDA representatives to participate in the scientific work of the European Pharmacopoeia Commission and other EDQM activities, to benefit from the EDQM’s experience in the field of medicinal products for human and veterinary use, to exchange with experts from European and international licensing authorities and inspectorates, and to take part in the work on the development of international quality controls for medicines and the methods of analysis used.